Shares of iShares Biotechnology ETF (NASDAQ:IBB) bought by State of Michigan Retirement System

State of Michigan Retirement System raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 150.0% during the second quarter, Holdings Channel reports. The fund owned 125,000 shares of the financial services provider’s stock after acquiring an additional 75,000 shares during the period. State of Michigan Retirement System’s holdings in iShares Biotechnology ETF were worth $17,158,000 as of its most recent SEC filing.

Other large investors have recently bought and sold shares of the company. Future Financial Wealth Managment LLC acquired a new stake in shares of iShares Biotechnology ETF in the 1st quarter valued at $27,000. Bbjs Financial Advisors LLC acquired a new position in iShares Biotechnology ETF in the second quarter valued at $31,000. Pacifica Partners Inc. boosted its holdings in iShares Biotechnology ETF by 118.2% in the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 130 shares during the last quarter. Crewe Advisors LLC boosted its stake in iShares Biotechnology ETF by 42.9% in the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after buying an additional 78 shares during the last quarter. Finally, YHB Investment Advisors Inc. acquired a new stake in iShares Biotechnology ETF in the 1st quarter worth about $37,000. Hedge funds and other institutional investors own 62.45% of the company’s shares.

iShares Biotechnology ETF stock down 0.0%

NASDAQ:IBB opened at $147.88 on Tuesday. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.17. The stock has a 50-day simple moving average of $142.43 and a 200-day simple moving average of $137.30.

Company Profile for iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that generally correspond to the price and return performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ-listed companies that are classified in accordance with the Industry Classification Standard as biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read more

Want to see what other hedge funds IBB owns? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).

Get daily news and ratings for the iShares Biotechnology ETF – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iShares Biotechnology ETF and related companies with MarketBeat.com’s FREE daily email newsletter.